Last reviewed: June 8, 2026

Last updated: June 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Many people wonder whether metformin belongs to the GLP-1 class of medications. The answer is no—metformin and GLP-1 drugs are distinct medications that work through separate biological mechanisms. Understanding these differences helps you make informed choices about your weight management and diabetes care.

What is Metformin and How Does It Work?

Metformin is an oral antidiabetic medication that has been used for decades to treat type 2 diabetes. It works primarily by reducing the amount of glucose your liver produces and improving how your body's cells respond to insulin. Unlike GLP-1 medications, metformin does not directly act on appetite-regulating hormones in your brain.

This medication is typically used to lower blood sugar levels and help prevent complications from diabetes. Metformin can also support modest weight loss in some patients, usually between 2 and 3 pounds on average over several months. However, its main purpose is glucose control rather than appetite suppression or significant weight reduction.

How GLP-1 Medications Differ from Metformin

GLP-1 medications like semaglutide activate specific receptors in your brain that regulate hunger and fullness signals. These drugs mimic glucagon-like peptide-1, a hormone your body naturally produces after eating. By enhancing this signaling pathway, GLP-1 medications reduce appetite, slow stomach emptying, and help you feel satisfied with smaller portions.

Clinical trials show that GLP-1 drugs produce significantly greater weight loss compared to metformin alone. Semaglutide users in major trials experienced average weight reductions of 15 to 22 percent of body weight, compared to much smaller losses with metformin. This fundamental difference in mechanism explains why GLP-1 medications have become a preferred choice for comprehensive weight management.

Can Metformin and GLP-1 Medications Be Used Together?

Yes, metformin and GLP-1 drugs can be prescribed together, and many healthcare providers recommend this combination for patients with type 2 diabetes who need both blood sugar control and weight loss support. The two medications work through different pathways, so they complement each other without direct interactions. This combination approach allows your doctor to address multiple aspects of metabolic health simultaneously.

If you are taking metformin and considering a GLP-1 medication like semaglutide, always discuss your current medications with your healthcare provider. PlexusDx semaglutide injection starts at $149 per month and works independently of metformin, giving you flexibility in how you layer treatments. Your provider can help determine whether combining these medications aligns with your individual health goals.

Choosing Between Metformin and GLP-1 for Weight Loss

If weight loss is your primary goal, GLP-1 medications like semaglutide or tirzepatide typically deliver more substantial results than metformin alone. Metformin is most effective when blood sugar management is the priority, though some weight loss may occur as a secondary benefit. Your choice depends on whether you have type 2 diabetes, prediabetes, or simply want to pursue weight management without a metabolic condition diagnosis.

PlexusDx offers the Precision Peptide Genetic Test to help personalize your treatment selection. This test analyzes genetic variants in key pathways—including the GLP1R and GIPR genes—that influence how your body responds to GLP-1 therapies. Understanding your genetic predisposition can guide whether semaglutide injection ($149/mo) or another GLP-1 option will be most effective for your unique biology.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is metformin a GLP-1 medication?

No. Metformin is a separate class of diabetes drug that lowers blood sugar by reducing liver glucose production and improving insulin sensitivity. GLP-1 medications work by activating appetite-control receptors in the brain. They are distinct medications with different mechanisms and outcomes.

Which medication causes more weight loss—metformin or GLP-1?

GLP-1 medications produce significantly greater weight loss. Semaglutide users in clinical trials lost 15 to 22 percent of body weight, while metformin typically results in 2 to 3 pounds of weight loss. If weight reduction is your main goal, GLP-1 therapy is the more effective choice.

Can I take metformin and semaglutide together?

Yes, many patients safely take both medications together. They work through different pathways and can complement each other for blood sugar control and weight loss. Always inform your healthcare provider about all current medications before starting semaglutide injection ($149/mo) through PlexusDx.

What are the side effects of metformin compared to GLP-1 drugs?

Metformin commonly causes gastrointestinal upset, including nausea and diarrhea, particularly when first starting. GLP-1 medications can also cause nausea initially, but many patients experience improvement as their body adjusts. Both are generally well-tolerated when dosed properly and monitored by a healthcare provider.

How does the Precision Peptide Genetic Test help choose between these medications?

PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month) analyzes variants in GLP1R, GIPR, FTO, and MC4R genes to predict how your body responds to GLP-1 therapy. These insights help your provider determine whether semaglutide or tirzepatide will be most effective for your specific genetic profile, optimizing your treatment plan.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves